240
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

Graphene quantum dots (GQDs) nanoarchitectonics for theranostic application in lung cancer

, , ORCID Icon &
Pages 269-286 | Received 01 Jun 2021, Accepted 24 Sep 2021, Published online: 29 Oct 2021

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
  • Li C, Lu H. Adenosquamous carcinoma of the lung. Onco Targets Ther. 2018;11:4829–4835.
  • Lortet-Tieulent J, Georges D, Bray F, et al. Profiling global cancer incidence and mortality by socioeconomic development. Int J Cancer. 2020;147(11):3029–3036.
  • Wang K, Liu Y, Hu T, et al. The treatment and outcome of a lung cancer patient infected with SARS-CoV-2. J Thorac Oncol. 2020;146:373–375.
  • Passaro A, Peters S, Mok TSK, et al. Testing for COVID-19 in lung cancer patients. Ann Oncol. 2020;31(7):832–834.
  • Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75(1):56–63.
  • de Mol M, Visser S, Aerts J, et al. Den oudsten B: the association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study. BMC Cancer. 2020;20(1):1–14.
  • Kumar V, Cohen JT, van Klaveren D, et al. Risk-targeted lung cancer screening: a cost-effectiveness analysis. Ann Intern Med. 2018;168(3):161–169.
  • Yuan M, Huang L-L, Chen J-H, et al. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Sig Transduct Target Ther. 2019;4(1):1–14.
  • Onoi K, Chihara Y, Uchino J, et al. Immune checkpoint inhibitors for lung cancer treatment: a review. JCM. 2020;9(5):1362.
  • Oronsky B, Reid TR, Oronsky A, et al. What’s new in SCLC? A review. Neoplasia. 2017;19(10):842–847.
  • Owen DH, Giffin MJ, Bailis JM, et al. DLL3: an emerging target in small cell lung cancer. J Hematol Oncol. 2019;12(1):61.
  • Salehi-Rad R, Li R, Paul MK, et al. The biology of lung cancer: development of more effective methods for prevention, diagnosis, and treatment. Clin Chest Med. 2020;41(1):25–38.
  • Ghalkhani M, Kaya SI, Bakirhan NK, et al. Application of nanomaterials in development of electrochemical sensors and drug delivery systems for anticancer drugs and cancer biomarkers. Crit Rev Anal Chem. 2020:1–23. DOI:https://doi.org/10.1080/10408347.2020.1808442
  • Nigam P, Waghmode S, Louis M, et al. Graphene quantum dots conjugated albumin nanoparticles for targeted drug delivery and imaging of pancreatic cancer. J Mater Chem B. 2014;2(21):3190–3195.
  • Yang Y, Yang X, Yang Y, et al. Aptamer-functionalized carbon nanomaterials electrochemical sensors for detecting cancer relevant biomolecules. Carbon. 2018;129:380–395.
  • Farzin L, Shamsipur M, Samandari L, et al. Recent advances in designing nanomaterial based biointerfaces for electrochemical biosensing cardiovascular biomarkers. J Pharm Biomed Anal. 2018;161:344–376.
  • Chen C, Wu Z, Ding P, et al. Peptide NGR modified TiO2 nanofiber substrate for circulating tumor cells capture. Adv Fiber Mater. 2020;2(4):186–193.
  • Malone ER, Oliva M, Sabatini PJB, et al. Molecular profiling for precision cancer therapies. Genome Med. 2020;12(1):8.
  • Gillet JP, Varma S, Gottesman MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst. 2013;105(7):452–458.
  • Testa U, Castelli G, Pelosi E. Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells. Cancers. 2018;10(8):248.
  • Li H, Takayama K, Wang S, et al. Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression. Cancer Chemother Pharmacol. 2014;74(6):1297–1305.
  • Jiang J, Liu Y, Wu C, et al. Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells. Drug Dev Ind Pharm. 2017;43(8):1304–1313.
  • Koizumi F, Shimoyama T, Taguchi F, et al. Establishment of a human non-small cell lung cancer cell line resistant to gefitinib. Int J Cancer. 2005;116(1):36–44.
  • Mohammad P, Nosratollah Z, Mohammad R, et al. The inhibitory effect of curcuma longa extract on telomerase activity in A549 lung cancer cell line. Afr J Biotechnol. 2010;9(6):912–919.
  • Srivastava RK, Pant AB, Kashyap MP, et al. Multi-walled carbon nanotubes induce oxidative stress and apoptosis in human lung cancer cell line-A549. Nanotoxicology. 2011;5(2):195–207.
  • Tabish TA, Pranjol MZI, Hayat H, et al. In vitro toxic effects of reduced graphene oxide nanosheets on lung cancer cells. Nanotechnology. 2017;28(50):504001.
  • Shao MX, Nakanaga T, Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol. 2004;287(2):L420–L427.
  • Sakamoto S, Inoue H, Kohda Y, et al. Interferon-Induced transmembrane protein 1 (IFITM1) promotes distant metastasis of small cell lung cancer. Int J Mol Sci. 2020;21(14):4934.
  • Park YH, Kim D, Dai J, et al. Human bronchial epithelial BEAS-2B cells, an appropriate in vitro model to study heavy metals induced carcinogenesis. Toxicol Appl Pharmacol. 2015;287(3):240–245.
  • Yang G, Li L, Lee WB, et al. Structure of graphene and its disorders: a review. Sci Technol Adv Mater. 2018;19(1):613–648.
  • Meyer JC, Geim AK, Katsnelson MI, et al. The structure of suspended graphene sheets. Nature. 2007;446(7131):60–63.
  • Green AA, Hersam MC. Solution phase production of graphene with controlled thickness via density differentiation. Nano Lett. 2009;9(12):4031–4036.
  • Jariwala D, Srivastava A, Ajayan PM. Graphene synthesis and band gap opening. J Nanosci Nanotechnol. 2011;11(8):6621–6641.
  • Valappil MO, Pillai VK, Alwarappan S. Spotlighting graphene quantum dots and beyond: synthesis, properties and sensing applications. Appl Mater Today. 2017;9:350–371.
  • Zhang X, Wei C, Li Y, et al. Shining luminescent graphene quantum dots: synthesis, physicochemical properties, and biomedical applications. Trac, Trends Anal Chem. 2019;116:109–121.
  • Jin SH, Kim DH, Jun GH, et al. Tuning the photoluminescence of graphene quantum dots through the charge transfer effect of functional groups. ACS Nano. 2013;7(2):1239–1245.
  • Tade RS, Patil PO. Theranostic prospects of graphene quantum dots in breast cancer. ACS Biomater Sci Eng. 2020;6(11):5987–6008.
  • Zhao C, Song X, Liu Y, et al. Synthesis of graphene quantum dots and their applications in drug delivery. J Nanobiotechnol. 2020;18(1):1–32.
  • Tade R, Nangare SN, Patil PO. Fundamental aspects of graphene and its biosensing applications. Funct Compos Struct. 2021;3(1):012001.
  • Tade RS, Nangare SN, Patil AG, et al. Recent advancement in bio-precursor derived graphene quantum dots: synthesis, characterization and toxicological perspective. Nanotechnology. 2020;31(29):292001.
  • Pierrat P, Gaumet J-J. Graphene quantum dots: emerging organic materials with remarkable and tunable luminescence features. Tetrahedron Lett. 2020;61(49):152554.
  • Bacon M, Bradley SJ, Nann T. Graphene quantum dots. Part Part Syst Charact. 2014;31(4):415–428.
  • Gao T, Wang X, Zhao J, et al. Bridge between temperature and light: bottom-up synthetic route to Structure-Defined graphene quantum dots as a temperature probe in vitro and in cells. ACS Appl Mater Interfaces. 2020;12(19):22002–22011.
  • Chua CK, Sofer Z, Simek P, et al. Synthesis of strongly fluorescent graphene quantum dots by cage-opening buckminsterfullerene. Acs Nano. 2015;9(3):2548–2555.
  • Zheng XT, Ananthanarayanan A, Luo KQ, et al. Glowing graphene quantum dots and carbon dots: properties, syntheses, and biological applications. Small. 2015;11(14):1620–1636.
  • Ding H, Yu S-B, Wei J-S, et al. Full-color light-emitting carbon dots with a surface-state-controlled luminescence mechanism. ACS Nano. 2016;10(1):484–491.
  • Hasan MT, Gonzalez‐Rodriguez R, Ryan C, et al. Photo‐and electroluminescence from nitrogen‐doped and nitrogen–sulfur codoped graphene quantum dots. Adv Funct Mater. 2018;28(42):1804337.
  • Qian Z, Ma J, Shan X, et al. Surface functionalization of graphene quantum dots with small organic molecules from photoluminescence modulation to bioimaging applications: an experimental and theoretical investigation. RSC Adv. 2013;3(34):14571–14579.
  • Liang L, Kong Z, Kang Z, et al. Theoretical evaluation on potential cytotoxicity of graphene quantum dots. ACS Biomater Sci Eng. 2016;2(11):1983–1991.
  • Liang L, Peng X, Sun F, et al. A review on the cytotoxicity of graphene quantum dots: from experiment to simulation. Nanoscale Adv. 2021;3(4):904–917.
  • Yuan X, Liu Z, Guo Z, et al. Cellular distribution and cytotoxicity of graphene quantum dots with different functional groups. Nanoscale Res Lett. 2014;9(1):108–109.
  • Wu C, Wang C, Han T, et al. Insight into the cellular internalization and cytotoxicity of graphene quantum dots. Adv Healthc Mater. 2013;2(12):1613–1619.
  • Li S, Su W, Wu H, et al. Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids. Nat Biomed Eng. 2020;4(7):704–716.
  • Wang X, Sun X, Lao J, et al. Multifunctional graphene quantum dots for simultaneous targeted cellular imaging and drug delivery. Colloids Surf B Biointerfaces. 2014;122:638–644.
  • Iannazzo D, Pistone A, Celesti C, et al. A smart nanovector for cancer targeted drug delivery based on graphene quantum dots. Nanomaterials. 2019;9(2):282.
  • Henna TK, Pramod K. Graphene quantum dots redefine nanobiomedicine. Mater Sci Eng C Mater Biol Appl. 2020;110:110651.
  • Yao X, Niu X, Ma K, et al. Graphene quantum dots‐capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy. Small. 2017;13(2):1602225.
  • Ding H, Zhang F, Zhao C, et al. Beyond a carrier: graphene quantum dots as a probe for programmatically monitoring anti-cancer drug delivery, release, and response. ACS Appl Mater Interfaces. 2017;9(33):27396–27401.
  • Kalkal A, Pradhan R, Kadian S, et al. Biofunctionalized graphene quantum dots based fluorescent biosensor toward efficient detection of small cell lung cancer. ACS Appl Bio Mater. 2020;3(8):4922–4932.
  • Campuzano S, Yáñez-Sedeño P, Pingarrón JM. Carbon dots and graphene quantum dots in electrochemical biosensing. Nanomaterials. 2019;9(4):634.
  • Shi J, Chan C, Pang Y, et al. A fluorescence resonance energy transfer (FRET) biosensor based on graphene quantum dots (GQDs) and gold nanoparticles (AuNPs) for the detection of mecA gene sequence of Staphylococcus aureus. Biosens Bioelectron. 2015;67:595–600.
  • Chung S, Revia RA, Zhang M. Graphene quantum dots and their applications in bioimaging, biosensing, and therapy. Adv Mater. 2021;33(22):1904362.
  • Xie R, Wang Z, Zhou W, et al. Graphene quantum dots as smart probes for biosensing. Anal Methods. 2016;8(20):4001–4016.
  • Hamburg MA. Science and regulation. FDA’s approach to regulation of products of nanotechnology. Science. 2012;336(6079):299–300.
  • Zhao J, Cui W. Functional electrospun fibers for local therapy of cancer. Adv Fiber Mater. 2020;2(5):229.
  • Fan HY, Yu XH, Wang K, et al. Graphene quantum dots (GQDs)-based nanomaterials for improving photodynamic therapy in cancer treatment. Eur J Med Chem. 2019;182:111620.
  • Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov. 2017;16(3):181–202.
  • Cao Y, Dong H, Yang Z, et al. Aptamer-conjugated graphene quantum dots/porphyrin derivative theranostic agent for intracellular cancer-related microRNA detection and fluorescence-guided photothermal/photodynamic synergetic therapy. ACS Appl Mater Interfaces. 2017;9(1):159–166.
  • Su YL, Yu TW, Chiang WH, et al. Hierarchically targeted and penetrated delivery of drugs to tumors by size‐changeable graphene quantum dot nanoaircrafts for photolytic therapy. Adv Funct Mater. 2017;27(23):1700056.
  • Kholikov K, Ilhom S, Sajjad M, et al. Improved singlet oxygen generation and antimicrobial activity of sulphur-doped graphene quantum dots coupled with methylene blue for photodynamic therapy applications. Photodiagnosis Photodyn Ther. 2018;24:7–14.
  • Yang C, Chan KK, Xu G, et al. Biodegradable polymer-coated multifunctional graphene quantum dots for light-triggered synergetic therapy of pancreatic cancer. ACS Appl Mater Interfaces. 2019;11(3):2768–2781.
  • Sung SY, Su YL, Cheng W, et al. Graphene quantum dots-mediated theranostic penetrative delivery of drug and photolytics in deep tumors by targeted biomimetic nanosponges. Nano Lett. 2019;19(1):69–81.
  • Xuan Y, Zhang R-Y, Zhao D-H, et al. Ultrafast synthesis of gold nanosphere cluster coated by graphene quantum dot for active targeting PA/CT imaging and near-infrared laser/pH-triggered chemo-photothermal synergistic tumor therapy. Chem Eng J. 2019;369:87–99.
  • Wang C, Chen Y, Xu Z, et al. Fabrication and characterization of novel cRGD modified graphene quantum dots for chemo-photothermal combination therapy. Sens Actuators, B. 2020;309:127732.
  • Raghunand N, Gillies RJ. pH and drug resistance in tumors. Drug Resist Updat. 2000;3(1):39–47.
  • Fan Z, Zhou S, Garcia C, et al. pH-Responsive fluorescent graphene quantum dots for fluorescence-guided cancer surgery and diagnosis. Nanoscale. 2017;9(15):4928–4933.
  • Nafiujjaman M, Khan HA, Lee Y-K. Peptide-influenced graphene quantum dots on iron oxide nanoparticles for dual imaging of lung cancer cells. J Nanosci Nanotechnol. 2017;17(3):1704–1711.
  • Sawy AM, Barhoum A, Abdel Gaber SA, et al. Insights of doxorubicin loaded graphene quantum dots: synthesis, DFT drug interactions, and cytotoxicity. Mater Sci Eng C Mater Biol Appl. 2021;122:111921.
  • Nahain A-A, Lee J-E, In I, et al. Target delivery and cell imaging using hyaluronic acid-functionalized graphene quantum dots. Mol Pharma. 2013;10(10):3736–3744.
  • Chen T, Yu H, Yang N, et al. Graphene quantum dot-capped mesoporous silica nanoparticles through an acid-cleavable acetal bond for intracellular drug delivery and imaging. J Mater Chem B. 2014;2(31):4979–4982.
  • Iannazzo D, Pistone A, Salamò M, et al. Graphene quantum dots for cancer targeted drug delivery. Int J Pharm. 2017;518(1–2):185–192.
  • Han W, Shi L, Ren L, et al. A nanomedicine approach enables co-delivery of cyclosporin a and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer. Signal Transduct Target Ther. 2018;3(1):16.
  • Chen F, Zhang H, Jiang L, et al. Enhancing the cytotoxic efficacy of combined effect of doxorubicin and cyclosporin encapsulated photoluminescent graphene dotted mesoporous nanoparticles against lung cancer cell-specific drug targeting for the nursing care of cancer patients. J Photochem Photobiol B. 2019;198:111578.
  • Karimi S, Namazi H. Simple preparation of maltose-functionalized dendrimer/graphene quantum dots as a pH-sensitive biocompatible carrier for targeted delivery of doxorubicin. Int J Biol Macromol. 2020;156:648–659.
  • Nurunnabi M, Khatun Z, Huh KM, et al. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano. 2013;7(8):6858–6867.
  • Chong Y, Ma Y, Shen H, et al. The in vitro and in vivo toxicity of graphene quantum dots. Biomaterials. 2014;35(19):5041–5048.
  • Xie Y, Wan B, Yang Y, et al. Cytotoxicity and autophagy induction by graphene quantum dots with different functional groups. J Environ Sci. 2019;77:198–209.
  • Tabish TA, Lin L, Ali M, et al. Investigating the bioavailability of graphene quantum dots in lung tissues via fourier transform infrared spectroscopy. Interface Focus. 2018;8(3):20170054.
  • Kersting D, Fasbender S, Pilch R, et al. From in vitro to ex vivo: subcellular localization and uptake of graphene quantum dots into solid tumors. Nanotechnology. 2019;30(39):395101.
  • Hashemi MS, Gharbi S, Jafarinejad-Farsangi S, et al. Secondary toxic effect of graphene oxide and graphene quantum dots alters the expression of miR-21 and miR-29a in human cell lines. Toxicol in Vitro. 2020;65:104796.
  • Wang S, Cole IS, Li Q. The toxicity of graphene quantum dots. RSC Adv. 2016;6(92):89867.
  • Tabish TA, Scotton CJ, J, Ferguson DC, et al. Biocompatibility and toxicity of graphene quantum dots for potential application in photodynamic therapy. Nanomedicine. 2018;13(15):1923–1937.
  • Yan C, Hu X, Guan P, et al. Highly biocompatible graphene quantum dots: green synthesis, toxicity comparison and fluorescence imaging. J Mater Sci. 2020;55(3):1198–1215.
  • Halder A, Godoy-Gallardo M, Ashley J, et al. One-pot green synthesis of biocompatible graphene quantum dots and their cell uptake studies. ACS Appl Bio Mater. 2018;1(2):452–461.
  • Lee NE, Jeong J-M, San Lim H, et al. Ultraviolet/blue light emitting high-quality graphene quantum dots and their biocompatibility. Carbon. 2020;170:213–219.
  • Hadad C, González-Domínguez JM, Armelloni S, et al. Graphene quantum dots: from efficient preparation to safe renal excretion. Nano Res. 2021;14(3):674–683.
  • Lin YH, Zhuang SX, Wang YL, et al. The effects of graphene quantum dots on the maturation of mouse oocytes and development of offspring. J Cell Physiol. 2019;234(8):13820–13831.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.